Raymond James & Associates’s Global Medical REIT GMRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $1.31M | Buy |
132,181
+2,938
| +2% | +$29.1K | ﹤0.01% | 2500 |
|
|
2024
Q2 | $1.17M | Buy |
129,243
+2,839
| +2% | +$25.8K | ﹤0.01% | 2504 |
|
|
2024
Q1 | $1.11M | Buy |
126,404
+4,533
| +4% | +$39.7K | ﹤0.01% | 2518 |
|
|
2023
Q4 | $1.35M | Buy |
121,871
+1,606
| +1% | +$17.8K | ﹤0.01% | 2329 |
|
|
2023
Q3 | $1.08M | Sell |
120,265
-5,448
| -4% | -$48.9K | ﹤0.01% | 2406 |
|
|
2023
Q2 | $1.15M | Sell |
125,713
-500
| -0.4% | -$4.57K | ﹤0.01% | 2375 |
|
|
2023
Q1 | $1.15M | Buy |
126,213
+97,323
| +337% | +$887K | ﹤0.01% | 2360 |
|
|
2022
Q4 | $274K | Sell |
28,890
-81,224
| -74% | -$770K | ﹤0.01% | 3255 |
|
|
2022
Q3 | $938K | Sell |
110,114
-4,864
| -4% | -$41.4K | ﹤0.01% | 2427 |
|
|
2022
Q2 | $1.29M | Sell |
114,978
-21,320
| -16% | -$239K | ﹤0.01% | 2279 |
|
|
2022
Q1 | $2.22M | Buy |
136,298
+15,528
| +13% | +$253K | ﹤0.01% | 2048 |
|
|
2021
Q4 | $2.14M | Sell |
120,770
-9
| -0% | -$160 | ﹤0.01% | 2129 |
|
|
2021
Q3 | $1.78M | Buy |
120,779
+12,816
| +12% | +$188K | ﹤0.01% | 2187 |
|
|
2021
Q2 | $1.59M | Buy |
107,963
+614
| +0.6% | +$9.07K | ﹤0.01% | 2257 |
|
|
2021
Q1 | $1.41M | Buy |
107,349
+4,488
| +4% | +$58.8K | ﹤0.01% | 2266 |
|
|
2020
Q4 | $1.34M | Buy |
102,861
+9,696
| +10% | +$127K | ﹤0.01% | 2136 |
|
|
2020
Q3 | $1.26M | Hold |
93,165
| – | – | ﹤0.01% | 2029 |
|
|
2020
Q2 | $1.06M | Sell |
93,165
-1,394
| -1% | -$15.8K | ﹤0.01% | 2123 |
|
|
2020
Q1 | $957K | Buy |
94,559
+4,993
| +6% | +$50.5K | ﹤0.01% | 2007 |
|
|
2019
Q4 | $1.19M | Buy |
89,566
+14,176
| +19% | +$188K | ﹤0.01% | 2167 |
|
|
2019
Q3 | $859K | Buy |
+75,390
| New | +$859K | ﹤0.01% | 2271 |
|